80 Beats Medical has been selected to join the 2026 Women’s Health Accelerator, led by Springboard Enterprises, a globally recognized program supporting high-growth companies advancing innovation in women’s healthcare.

‍

The accelerator brings together an exceptional cohort of women-led startups working across reproductive health, fertility, maternal health, diagnostics, therapeutics, and medical technologies. Over the coming months, participating companies will engage in an intensive program of mentorship, strategic guidance, and investor exposure designed to accelerate growth and impact.

‍

80 Beats Medical is focused on improving the diagnosis of cardiovascular disease in women, with a particular emphasis on the early detection and management of preeclampsia, a leading cause of maternal and long-term cardiovascular complications worldwide.

‍

Through the program, 80 Beats Medical will gain access to Springboard’s extensive network of experienced advisors, healthcare leaders, corporate partners, and investors focused on improving outcomes for women worldwide.

‍

“Being selected for this cohort is both an honor and an important milestone for our company,” said Laura Jassoy, Managing Director at 80 Beats Medical. “I am excited to collaborate with fellow founders and leverage the program’s expertise to accelerate our mission to transform women’s health.”

‍

The 2026 cohort reflects the growing momentum in the women’s health sector, addressing long-standing gaps in care through innovative technologies and new models of delivery. Participation in the accelerator will support 80 Beats Medical’s continued development and international expansion as it works to improve health outcomes for women globally.

‍

We look forward to the months ahead and to contributing to a stronger, more equitable future for women’s healthcare. Learn more about the Springboard Women’s Health Accelerator at sb.co.

‍